When surveyed, many physicians said the belief that patients had adequate symptom control was why they didn’t add more meds.

Immunoglobulin A nephropathy (known as IgA nephropathy or Berger's disease) is a rare kidney disease that occurs when the ...

A recent study suggests that a class of diabetes medications could be linked to a reduced risk of developing dementia ...

Diabetes medications, specifically sodium-glucose cotransporter-2 (SGLT2) inhibitors, may be linked to a decreased risk of ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson’s disease, according to a study ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...